Cargando…

Novel drug delivery systems for inflammatory bowel disease

Inflammatory bowel disease (IBD) is a chronic illness characterized by relapsing inflammation of the intestines. The disorder is stratified according to the severity and is marked by its two main phenotypical representations: Ulcerative colitis and Crohn’s disease. Pathogenesis of the disease is amb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yasmin, Farah, Najeeb, Hala, Shaikh, Shehryar, Hasanain, Muhammad, Naeem, Unaiza, Moeed, Abdul, Koritala, Thoyaja, Hasan, Syedadeel, Surani, Salim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150062/ https://www.ncbi.nlm.nih.gov/pubmed/35664964 http://dx.doi.org/10.3748/wjg.v28.i18.1922

Ejemplares similares

Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease
por: Yasmin, Farah, et al.
Publicado: (2022)

Electrical neuromodulation therapy for inflammatory bowel disease
por: Yasmin, Farah, et al.
Publicado: (2022)

Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients
por: Najeeb, Hala, et al.
Publicado: (2022)

Incidence, predictors, and outcomes of early hospital readmissions after kidney transplantation: Systemic review and meta-analysis
por: Iqbal, Kinza, et al.
Publicado: (2022)

Integration and implementation of precision medicine in the multifaceted inflammatory bowel disease
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

COVID-19 Vaccine Hesitancy in the United States: A Systematic Review
por: Yasmin, Farah, et al.
Publicado: (2021)

Safety and efficacy of colchicine in COVID-19 patients: A systematic review and meta-analysis of randomized control trials
por: Yasmin, Farah, et al.
Publicado: (2022)

Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
por: Yasmin, Farah, et al.
Publicado: (2023)

Self-Medication Practices in Medical Students During the COVID-19 Pandemic: A Cross-Sectional Analysis
por: Yasmin, Farah, et al.
Publicado: (2022)

Diabetes among Muslims during Ramadan: A narrative review
por: Ochani, Rohan Kumar, et al.
Publicado: (2023)

Genomics in medicine: A new era in medicine
por: Pattan, Vishwanath, et al.
Publicado: (2021)

Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring
por: Albader, Farah, et al.
Publicado: (2021)

Acute exacerbation of interstitial lung disease in the intensive care unit: Principles of diagnostic evaluation and management
por: Hayat Syed, Muhammad K, et al.
Publicado: (2023)

Abdominal compartment syndrome: Often overlooked conditions in medical intensive care units
por: Rajasurya, Venkat, et al.
Publicado: (2020)

Mediastinal lymphadenopathy in COVID-19: A review of literature
por: Taweesedt, Pahnwat Tonya, et al.
Publicado: (2021)

Inflammatory bowel disease and airway diseases
por: Vutcovici, Maria, et al.
Publicado: (2016)

Biosimilars in paediatric inflammatory bowel disease
por: Sieczkowska-Golub, Joanna, et al.
Publicado: (2018)

Combination therapy for inflammatory bowel disease
por: Sultan, Keith S, et al.
Publicado: (2017)

Food as Treatment of Inflammatory Bowel Diseases
por: Maldonado-Contreras, Ana
Publicado: (2022)

Effects of diabetic ketoacidosis in the respiratory system
por: Gallo de Moraes, Alice, et al.
Publicado: (2019)

Interstitial lung disease and diabetes
por: Rajasurya, Venkat, et al.
Publicado: (2020)

Hepatic hemangioma: What internists need to know
por: Leon, Monica, et al.
Publicado: (2020)

Abdominal compartment syndrome among surgical patients
por: Leon, Monica, et al.
Publicado: (2021)

Non-clostridium difficile induced pseudomembranous colitis
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

Critically ill patients and gut motility: Are we addressing it?
por: Vazquez-Sandoval, Alfredo, et al.
Publicado: (2017)

Anti-integrin therapy for inflammatory bowel disease
por: Park, Sung Chul, et al.
Publicado: (2018)

Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities
por: Lippi, Giuseppe, et al.
Publicado: (2017)

Enteroscopy in children and adults with inflammatory bowel disease
por: Di Nardo, Giovanni, et al.
Publicado: (2020)

Proteomic insights on the metabolism in inflammatory bowel disease
por: Pisani, Laura Francesca, et al.
Publicado: (2020)

Role of diet and nutrition in inflammatory bowel disease
por: de Castro, Marina Moreira, et al.
Publicado: (2021)

Efficacy and safety of finerenone in chronic kidney disease and type 2 diabetes patients: a systematic review and meta-analysis
por: Yasmin, Farah, et al.
Publicado: (2023)

Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: What factors to consider?
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2023)

Guidelines and controversies in the management of diabetic ketoacidosis – A mini-review
por: Islam, Tasnim, et al.
Publicado: (2018)

Fungal infections following liver transplantation
por: Khalid, Madiha, et al.
Publicado: (2021)

Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases
por: Akiyama, Shintaro, et al.
Publicado: (2022)

Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease
por: Tighe, Donal, et al.
Publicado: (2017)

Necroptosis in inflammatory bowel disease and other intestinal diseases
por: Li, Sha, et al.
Publicado: (2018)

Potential role of nutraceutical compounds in inflammatory bowel disease
por: Larussa, Tiziana, et al.
Publicado: (2017)

Sexual health and fertility for individuals with inflammatory bowel disease
por: Leenhardt, Romain, et al.
Publicado: (2019)

Emerging use of artificial intelligence in inflammatory bowel disease
por: Kohli, Arushi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cjm3p28g9dk3u4qjqltufpg7n1